Steven Avruch
Director/Board Member at Boston Center for the Arts
Net worth: 30 107 $ as of 2024-06-29
Steven Avruch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Boston Center for the Arts | Director/Board Member | - | - |
Career history of Steven Avruch
Former positions of Steven Avruch
| Companies | Position | Start | End |
|---|---|---|---|
| TECTONIC THERAPEUTIC, INC. | General Counsel | 2019-01-01 | 2024-06-19 |
| Corporate Secretary | 2019-01-01 | 2024-06-19 | |
| BIOGEN INC. | General Counsel | 2013-02-28 | 2017-11-30 |
Training of Steven Avruch
| Boston College Law School | Graduate Degree |
| Dartmouth College | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| General Counsel | 2 |
| Corporate Secretary | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Avrobio, Inc.
 Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
| Boston Center for the Arts |
- Stock Market
- Insiders
- Steven Avruch
- Experience
